Form 8-K

Date: May 21, 2013

PATHEON INC.

/s/ James C. Mullen

James C. Mullen

Chief Executive Officer

0001193125-13-229893.txt : 20130521 0001193125-13-229893.hdr.sgml : 20130521 20130521172033 ACCESSION NUMBER: 0001193125-13-229893 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130517 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20130521 DATE AS OF CHANGE: 20130521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PATHEON INC CENTRAL INDEX KEY: 0001400431 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54283 FILM NUMBER: 13862741 BUSINESS ADDRESS: STREET 1: C/O PATHEON PHARMACEUTICALS SERVICES INC STREET 2: 4721 EMPEROR BOULEVARD, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 905-821-4001 MAIL ADDRESS: STREET 1: 2100 SYNTEX COURT CITY: MISSISSAUGA STATE: A6 ZIP: L5N 7K9 8-K 1 d542248d8k.htm FORM 8-K Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 17, 2013

PATHEON INC.

(Exact name of registrant as specified in its charter)

Canada

000-54283

Not Applicable

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

c/o Patheon Pharmaceuticals Services Inc.

4721 Emperor Boulevard, Suite 200

Durham, NC

27703

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (919) 226-3200

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 17, 2013, Antonella Mancuso, President, Global Commercial Operations and Chief Manufacturing Officer for Patheon Inc. (the “Company”), notified the Company that she plans to resign from her positions with the Company and its subsidiaries, effective July 10, 2013.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.